| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
2 companies
Hill Emily Luisa is a Chief Financial Officer at Replimune Group, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $3.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | REPL Replimune Group, Inc. | Chief Financial Officer | Sell | 9,154 | $5.37 | $49,156.98 | -6.4% | +61.5% | - | |
| May 20, 2025 | REPL Replimune Group, Inc. | Chief Financial Officer | Sell | 2,535 | $8.05 | $20,406.75 | -1.7% | -42.0% | - | |
| Aug 16, 2024 | REPL Replimune Group, Inc. | Chief Financial Officer | Sell | 8,938 | $10.18 | $90,988.84 | -8.1% | +12.8% | -45.0% | |
| Mar 27, 2023 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 7,363 | $45.00 | $331,335.00 | -15.9% | -11.7% | -38.9% | |
| Jan 31, 2023 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 575 | $45.63 | $26,236.10 | -1.2% | +20.2% | -43.1% | |
| Jan 24, 2023 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 223 | $47.45 | $10,581.64 | -0.5% | +11.8% | -42.4% | |
| Jan 11, 2023 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 915 | $43.58 | $39,879.96 | -1.0% | +6.1% | -37.1% | |
| Jan 9, 2023 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 758 | $41.66 | $31,575.40 | -1.6% | +16.9% | -31.0% | |
| Mar 31, 2022 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 7,910 | $37.78 | $298,823.98 | -21.3% | +8.3% | +29.8% | |
| Feb 1, 2022 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 553 | $40.00 | $22,121.11 | -1.5% | -10.7% | +16.9% |